Management of Portal Hypertension

  • Yolanda Y. L. Yang
  • J. Michael Henderson

Case Report

A 37-year-old woman with a history of hepatitis C, cirrhosis, and esophageal varices presented with hematemesis and melena. The patient had a history of a prior esophageal variceal bleeding episode 7 years ago, which required transfusion of four units of packed red blood cells (PRBC) and had been treated with endoscopic sclerotherapy. She was placed on nadolol at that time.

Question 1

If the patient had been found to have varices before any bleeding episode, she would benefit from which of the following?
  1. A.

    Endoscopic treatment: sclerotherapy or band ligation.

  2. B.

    Transjugular intrahepatic portal systemic shunt (TIPS).

  3. C.

    Non-cardioselective beta-blocker.

  4. D.

    A surgical shunt.


The patient re-presents 1 year prior to her current admission with a further variceal bleed documented at endoscopy, which required five units of PRBC. The acute episode of bleeding was managed with variceal banding, and the patient underwent a course of banding on an outpatient basis. She had...


  1. 1.
    Costa G, Cruz RJ Jr, Abu-Elmagd KM. Surgical shunt versus TIPS for treatment of variceal hemorrhage in the current era of liver and multivisceral transplantation. Surg Clin North Am. 2010 Aug; 90(4):891–905.Google Scholar
  2. 2.
    Garcia-Tsao G, Abraldes J, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis and management - 2016 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2017; 65: 310–335.Google Scholar
  3. 3.
    Patidar KR, Sydnor M, Sanyal AJ. Transjugular intrahepatic portosystemic shunt. Clin Liver Dis. 201;18(4):853–76.Google Scholar
  4. 4.
    Schepke M, Kleber G, Nurnberg D, et al. Ligation versus propanolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004;40:65–72.CrossRefPubMedGoogle Scholar
  5. 5.
    Sarin SK, Lamba GS, Kumar M, Murthy NS. Comparison of endoscopic ligation and propanolol for the primary prevention of variceal bleeding. N Engl J Med. 1999;340:988–93.CrossRefPubMedGoogle Scholar
  6. 6.
    Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology. 1998;28:868–80.CrossRefPubMedGoogle Scholar
  7. 7.
    Boyer TD, Haskal ZJ, AASLD Pract Guidel. The role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. Hepatology. 2005;41:386–400.CrossRefPubMedGoogle Scholar
  8. 8.
    Henderson JM. Distal splenorenal shunt. In: Blumgart LH, editor. Surgery if the liver, biliary tract, and pancreas. 4th ed. Sect XV, Chap 98. 2005, in press.Google Scholar
  9. 9.
    Rosemurgy AS, Serafini FM, Zweibel BR, et al. Transjugular intrahepatic portosystemeic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg. 2000;4:589–97.CrossRefPubMedGoogle Scholar
  10. 10.
    Henderson JM, Boyer TD, Kutner MH, et al. and the DIVERT study group. DSRS vs. TIPS for refractory variceal bleeding: a prospective randomized controlled trial. Gastroenterology. 2006;130:1643–51.Google Scholar
  11. 11.
    Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using PTFE coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.San FranciscoUSA
  2. 2.University of Mississippi Medical CenterJacksonUSA

Personalised recommendations